text: Company looks to new drugs in face of patent expirations BOSTON (CBS.MW) -- With the threat of generic competition looming over the pharmaceutical industry, Pfizer Inc. declared on Tuesday that the strength and breadth of its drugs under development will give the company an edge over its rivals.